Thyrotropin-Releasing Hormone (TRH): The Smallest Hormone and the TRH Stimulation Test

Thyrotropin-releasing hormone (TRH) is a contender for the title of smallest hormone in the body: just three amino acids (pyroglutamyl-histidyl-proline amide). Despite that minimalism, it sits at the very top of the thyroid axis and helps govern one of metabolism's master controls. Its synthetic form, protirelin, gave endocrinology one of its classic dynamic tests.

The thyroid axis in brief

Like the other hypothalamic axes, the thyroid system is a cascade:

1. The hypothalamus releases TRH.
2. TRH tells the pituitary to release thyroid-stimulating hormone (TSH).
3. TSH tells the thyroid gland to make the thyroid hormones T4 and T3, which set the body's metabolic rate.

Thyroid hormones feed back to suppress TRH and TSH, keeping the loop balanced. TRH has a second job too: it is a potent stimulus for the pituitary to release prolactin, the hormone of lactation — which is why some conditions raise both TSH and prolactin together.

The TRH stimulation test

Because TRH triggers a fast, measurable release of TSH, injecting synthetic TRH (protirelin) and watching the TSH response became a way to probe pituitary function. In the classic TRH stimulation test:

• Baseline TSH (and sometimes prolactin) is drawn.
• Protirelin is injected.
• TSH is measured again over the next 30–60 minutes.

The shape of the response is informative. An exaggerated TSH rise can occur in primary hypothyroidism (the pituitary is already straining) or point to certain pituitary patterns. A flat, absent response is seen in hyperthyroidism (the pituitary is suppressed by high thyroid hormone) and in some pituitary disease.

Why the test faded — and where it still helps

For decades the TRH test was a mainstay for detecting subtle thyroid dysfunction, because older TSH assays couldn't measure very low levels. The arrival of sensitive third-generation TSH assays, which measure suppression directly from a single blood draw, removed much of that need. Today the TRH test is used selectively — for example in evaluating central (pituitary) hypothyroidism, characterizing certain pituitary tumors, and in research on the thyroid and prolactin systems.

A characteristic sensation

People often notice brief, harmless effects moments after a protirelin injection: a sudden urge to urinate, a metallic taste, flushing, or a short-lived blood-pressure change. These pass within minutes and are a well-known feature of the test rather than a cause for concern.

One family of releasing-hormone tests

TRH testing belongs to the same conceptual family as the other hypothalamic releasing-hormone probes: corticorelin (CRH) for the adrenal axis, and gonadorelin (GnRH) for the reproductive axis. In each case a tiny hypothalamic peptide, given as a drug, lets clinicians interrogate the pituitary's ability to respond — a recurring theme in endocrine diagnosis.

> This article is educational and not medical advice. TRH testing is arranged and interpreted by clinicians.